Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023243 · ClinicalTrials.gov registry record · NA
Natural Language Processing and Quality Assessment in Primary Care
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 389
- Enrollment target
NCT01023243: Completed NA study, sponsored by Mayo Clinic.
NCT01023243 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 389 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01023243, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 389 participants
- Enrollment target
Study Summary
The investigators propose to use a Natural Language Processing System (NLP) to provide an initial baseline report for primary care patients at risk for diabetes and cardiovascular complications that will include: a) evidence of foot exam documentation in the previous year; b) use of aspirin for cardiovascular risk reduction; and c) tobacco use. As part of a randomized trial, we plan to use a previously validated mailed survey (NCQA Provider Recognition Program) that requests information on the last foot exam, use of aspirin and tobacco. Patients who have been identified by NLP as not having had a foot exam will be randomized into treatment and control arms. Both arms will receive an informational letter; with a second mailing to nonresponders after one month, describing the key strategies for effective patient-physician communication during the clinical encounter. The treatment arm will also receive an informational letter and patient education brochure containing key messages about the importance of regular foot examinations. NLP will be repeated after 6 months to compare the impact of the patient education materials.
Interventions
- OTHER Brochure: Care of the Feet for Those at Risk
- OTHER Quality Survey: foot exam, tobacco and aspirin use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 389 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01023243
The ClinicalTrials.gov registry entry for NCT01023243 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 389 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brochure: Care of the Feet for Those at Risk is the first listed.
NCT01023243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01023243 about?
NCT01023243 is a clinical study titled "Natural Language Processing and Quality Assessment in Primary Care". The investigators propose to use a Natural Language Processing System (NLP) to provide an initial baseline report for primary care patients at risk for diabetes and cardiovascular complications that will include: a) evidence of foot exam documentation in the previous year; b) use of aspirin for card...
What is the current status of trial NCT01023243?
This trial is currently completed. It is a NA study. The enrollment target is 389 participants. The study started on 2010-01. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01023243?
The interventions under investigation include: Brochure: Care of the Feet for Those at Risk (OTHER), Quality Survey: foot exam, tobacco and aspirin use (OTHER).
Who is sponsoring clinical trial NCT01023243?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.